New products
Viome PRO introduces blood test for pancreatic cancer
Viome Life Sciences' clinical division Viome PRO launched CancerDetect Pancreatic, a physician-ordered blood test for detecting pancreatic ductal adenocarcinoma. The test represents a new product offering in the company's cancer diagnostics portfolio and targets early detection in a disease with historically poor prognosis.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network